Inventor
Erhard Kopetzki
Inventor
Penzberg, DE
Overview
Patents· 51 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides30%
C12NMicroorganisms or enzymes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations9%
A61KPreparations for medical, dental or toiletry purposes7%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
C12YEnzymes3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms1%
PatentTitleYear
11,098,338Recombinant polypeptide production methods202110,836,816Fusion proteins for opthalmology with increased eye retention202010,370,692Recombinant polypeptide production methods201910,280,214Glycosylated repeat-motif-molecule conjugates201910,155,970Use of an amino acid auxotrophy cured prokaryotic strain for the recombinant production of a polypeptide201810,106,600Bispecific antibodies201810,106,612Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof20189,926,567'Promoter'20189,487,576'Method for reduction of 1->2 reading frame shifts'20169,428,766'Protein expression from multiple nucleic acids'20169,403,896'Serpin-finger fusion polypeptide'20169,382,323'Multispecific antibodies comprising full length antibodies and single chain fab fragments'20169,080,183'Promoter'20158,877,895'Prokaryotic expression construct'20148,771,988'Protein expression from multiple nucleic acids'20148,541,204'Polypeptide producing cells'2013RE044389'Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies'2013RE044359'Nucleic acid molecules encoding anti-P-selectin antibodies'20138,354,516'Polypeptide producing cells'20138,314,225'Heavy chain mutant leading to improved immunoglobulin production'2012RE043568'Anti-P-selectin antibodies'20127,981,635'Cleavage of precursors of insulins by a variant of trypsin'20117,951,920'Conjugate of an antibody against CCR5 and an antifusogenic peptide'20117,892,790'Protein expression in rodent cells'20117,824,684'Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies'20107,807,409'Method for the recombinant expression of a polypeptide'20107,754,867'Nucleic acid molecules encoding anti-P-selectin antibodies'20107,579,157'Antibody selection method against IGF-IR'20097,572,897'Antibodies against insulin-like growth factor I receptor and uses thereof'20097,563,441'Anti-P-selectin antibodies'20097,378,503'Antibodies against insulin-like growth factor 1 receptor and uses thereof'20087,034,119'Method for recombinant production of polypeptides'20066,660,492'Chimeric serine proteases'20036,391,571'Recombinant inactive avidin mutants'20026,312,916'Recombinant inactive core streptavidin mutants'20016,291,245'Host-vector system'20016,284,484'Process for the production of proteins in soluble form by modulation of an inducible promoter'20016,277,618'Recombinant blood-coagulation proteases'20016,171,842'Chimeric serine proteases'20016,159,722'Chimeric serine proteases'20006,153,192'Peptides with a characteristic antigenic determinant of .alpha.1-microglobulin'20006,136,564'Process for the production of peptides by way of streptavidin fusion proteins'20005,834,224'Electrochemical sensor containing an enzyme linked to binding molecules bound to a noble metal surface'19985,798,226'Yeast host strains with defects in N-glycosylation'19985,705,616'Proteins from yeast host strains with defects in N-glycosylation'19985,672,691'Recombinant core streptavidin'19975,602,018'Hypoglycosylated recombinant glucose oxidases'19975,489,528'Recombinant core-streptavidin'19965,434,067'Process for the production and renaturation of recombinant, biologically active, eukaryotic alkaline phosphatase'19955,310,876'Expression of HIV1 and HIV2 polypeptides and their use'19945,179,003'Process for the production of proteins or protein-containing gene products'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993–2003Patents assigned to BOEHRINGER MANNHEIM GMBH (13)· patent assignee history
1993Based in Tutzing, DE· patent location history
1994–2021Based in Penzberg, DE· patent location history
2000–2002Patents assigned to ROCHE DIAGNOSTICS GMBH (6)· patent assignee history
2001Based in Deutschland, DE· patent location history
2006–2021Patents assigned to HOFFMANN LA ROCHE (27)· patent assignee history
2012–2019Patents assigned to KOPETZKI ERHARD (10)· patent assignee history
2015–2018Patents assigned to KLEIN CHRISTIAN (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HOFFMANN LA ROCHE | 27 | 2006–2021 |
| BOEHRINGER MANNHEIM GMBH | 13 | 1993–2003 |
| KOPETZKI ERHARDself | 10 | 2012–2019 |
| ROCHE DIAGNOSTICS GMBH | 6 | 2000–2002 |
| KLEIN CHRISTIAN | 3 | 2015–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Penzberg, DE | 49 | 1994–2021 |
| Deutschland, DE | 1 | 2001 |
| Tutzing, DE | 1 | 1993 |